Results 91 to 100 of about 22,433 (204)
Evaluation of Naltrexone as a treatment for amphetamine dependence
, 2007 Amphetamine addiction is a disease that affects millions of people worldwide and lacks effective treatment. An estimated 35 million persons are reported to abuse amphetamines, which is more than the total number of cocaine and heroin abusers combined.
Nitya Jayaram-Lindström (317917)
core
Obesity, Volume 34, Issue 6, Page 1237-1242, June 2026.ABSTRACT Objective This study aimed to describe parental communication with children around obesity management medications (OMMs) and child, parent, and family factors associated with communication. Methods Parents (N = 211; 80% mothers; 89% White) prescribed OMMs at a medical center participated in a survey about communication with children about OMM ...
Keeley J. Pratt +3 more
wiley +1 more source
Naltrexone for the management of opioid dependence.
, 2007 Naltrexone is recommended as a treatment option for people who have been opioid dependent but who have stopped using opioids, and who are highly motivated to stay free from the drugs in an abstinence programme.
core
Health Care Costs and Use of Patients Prescribed Four Different Obesity Medications
Obesity, Volume 34, Issue 6, Page 1331-1342, June 2026.ABSTRACT Objective This study compared changes in health care costs and use across cohorts initiating four obesity medications (OMs). Methods Commercial insurance claims were used to identify new initiators of phentermine (n = 136,788), phentermine‐topiramate‐ER (n = 13,888), naltrexone‐bupropion‐SR (n = 28,712), or liraglutide (n = 49,266) for obesity.
Kristina H. Lewis +10 more
wiley +1 more source
, 1992 The pourpose of the present study was to evaluate naltrexone and 6-b-naltrexol plasma time course during long term treatment in the usual clinical setting, in drug addicts.
Dell'Utri A +7 more
core
Effective Management of Recalcitrant Hailey–Hailey Disease With Risankizumab
International Journal of Dermatology, Volume 65, Issue 7, Page 1457-1459, July 2026.
Joy Justice +3 more
wiley +1 more source
Obesity, Volume 34, Issue 6, Page 1343-1353, June 2026.ABSTRACT Objective This study evaluated the association between antiobesity medications (AOM) and incident cardiovascular disease (CVD) among older women, examining this relationship within and across survivors of obesity‐related cancers (ORCa) and age‐matched cancer‐free populations.
David S. Lopez +10 more
wiley +1 more source
Insurance Coverage and Provision of Opioid Disorder Treatment: Evidence From Medicare
Journal of Policy Analysis and Management, Volume 45, Issue 3, Summer 2026.ABSTRACT Older adult opioid overdose deaths have increased over the past two decades in the United States. Methadone, one of three medications approved for opioid use disorder (OUD) treatment, was not covered by Medicare—the primary insurer of Americans 65 years and older—for OUD until 2020.
Denis Agniel +4 more
wiley +1 more source
Naltrexone attenuates endoplasmic reticulum stress induced hepatic injury in mice
Endoplasmic reticulum (ER) stress provides abnormalities in insulin action, inflammatory responses, lipoprotein B100 degradation and hepatic lipogenesis.
Nahrevanian, H. +7 more
core +1 more source
Aging Cell, Volume 25, Issue 6, June 2026.Supplement users have lower epigenetic biological age than non‐users. Several supplements or supplement classes are associated with some benefit on epigenetic age in either cross‐sectional or longitudinal analyses. ABSTRACT In this cross‐sectional cohort we analyzed data from 4260 “health enthusiasts” who purchased at least one saliva‐based DNA ...
Kamil Pabis +6 more
wiley +1 more source